Literature DB >> 27330585

Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control.

Khaireddine Bouassida1, Mehdi Jaidane1, Olfa Bouallegue2, Ghassen Tlili1, Habiba Naija2, Ali Tahar Mosbah1.   

Abstract

INTRODUCTION: Our goal was to investigate the prevalence and antibiogram pattern of extended spectrum beta-lactamase (ESBL) production among uropathogens using isolates from urine samples collected at the Department of Urology in the Sahloul Hospital, Tunisia We also aimed to identify the risk factors for nosocomial urinary tract infections (UTIs) in patients who underwent transurethral resection of the prostate (TURP) and the measures for infection control.
METHODS: Laboratory records of a five-year period from January 2004 to December 2008 were submitted for retrospective analysis to determine the incidence of ESBL infections. A total of 276 isolates were collected. A case-control study involving comparisons between two groups of patients who underwent TURP was performed to determine the risk factors for ESBL infection. Group 1, designated case subjects, included 51 patients with nosocomial UTI after TURP. Group 2, designated control subjects, consisted of 58 randomly selected patients who underwent TURP without nosocomial UTI in the same period. Factors suspected to be implicated in the emergence of ESBL infection were compared between the two groups in order to identify risk factors for infection. A univariate regression analysis was performed, followed by a multivariate one.
RESULTS: The annual prevalence of ESBL infection ranged from 1.3-2.5%. After performing univariate and multivariate regression analysis, the main risk factors for ESBL infections were identified as: use of antibiotics the year preceding the admission, duration of catheter use, and bladder washout (p=0.012, p=0.019, and p<0.001.
CONCLUSIONS: Urologists have to perform a good hemostasis, especially in endoscopic resections, in order to avoid bladder irrigation and bladder washout and to reduce the time of bladder catheterization, which is a strong risk factor of nosocomial UTIs.

Entities:  

Year:  2016        PMID: 27330585      PMCID: PMC4907780          DOI: 10.5489/cuaj.3223

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  30 in total

1.  Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Juan C Alcalá; Jose M Cisneros; Fabio Grill; Antonio Oliver; Juan P Horcajada; Teresa Tórtola; Beatriz Mirelis; Gemma Navarro; María Cuenca; María Esteve; Carmen Peña; Ana C Llanos; Rafael Cantón; Alvaro Pascual
Journal:  Arch Intern Med       Date:  2008-09-22

2.  Factors predisposing to bacteriuria during indwelling urethral catheterization.

Authors:  R A Garibaldi; J P Burke; M L Dickman; C B Smith
Journal:  N Engl J Med       Date:  1974-08-01       Impact factor: 91.245

3.  Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.

Authors:  Ya-Sung Yang; Chih-Hung Ku; Jung-Chung Lin; Shih-Ta Shang; Chun-Hsiang Chiu; Kuo-Ming Yeh; Chu-Chun Lin; Feng-Yee Chang
Journal:  J Microbiol Immunol Infect       Date:  2010-06       Impact factor: 4.399

Review 4.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Javier Ena; Francisco Arjona; Carmen Martínez-Peinado; Maria Del Mar López-Perezagua; Concepción Amador
Journal:  Urology       Date:  2006-12       Impact factor: 2.649

6.  Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Authors:  Esther Calbo; Verónica Romaní; Mariona Xercavins; Lucía Gómez; Carolina Garcia Vidal; Salvador Quintana; Jordi Vila; Javier Garau
Journal:  J Antimicrob Chemother       Date:  2006-02-21       Impact factor: 5.790

7.  Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients.

Authors:  A I Hartstein; S B Garber; T T Ward; S R Jones; V H Morthland
Journal:  Infect Control       Date:  1981 Sep-Oct

8.  Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.

Authors:  M Ortega; F Marco; A Soriano; M Almela; J A Martínez; A Muñoz; J Mensa
Journal:  J Antimicrob Chemother       Date:  2009-01-06       Impact factor: 5.790

9.  Prevalence of extended spectrum -lactamase producing Klebsiella pneumoniae in a tertiary care hospital.

Authors:  I Shukla; R Tiwari; M Agrawal
Journal:  Indian J Med Microbiol       Date:  2004 Apr-Jun       Impact factor: 0.985

10.  Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.

Authors:  S P Kuster; B Hasse; V Huebner; V Bansal; R Zbinden; C Ruef; B Ledergerber; R Weber
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553

View more
  3 in total

Review 1.  A systematic review of healthcare-associated infections in Africa: An antimicrobial resistance perspective.

Authors:  Emmanuel O Irek; Adewale A Amupitan; Temitope O Obadare; Aaron O Aboderin
Journal:  Afr J Lab Med       Date:  2018-12-06

2.  Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013-2016) study from Aseer region, Saudi Arabia.

Authors:  Abdulaziz Alamri; Mohamed E Hamid; Muhammad Abid; Abdulrahman M Alwahhabi; Khalid M Alqahtani; Mohammed S Alqarni; Mosleh Abomughaid
Journal:  Urol Ann       Date:  2018 Jan-Mar

3.  Epidemiology of resistance and phenotypic characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae isolates at Sahloul University Hospital-Sousse, Tunisia.

Authors:  Aziza Messaoudi; Wejdène Mansour; Nedia Jaidane; Chrifa Chaouch; Noureddine Boujaâfar; Olfa Bouallègue
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.